4:00 PM Frankfurt Adecco agreed to acquire the U.S.-based General Assembly. Rocket Internet plans early termination of its share buyback program. Software AG reported weaker-than-expected revenues. Shire agreed to sell its Oncology business to France-based Servier.
In London trading, FTSE 100 index fell 50.15 or 0.7% to 7,216.05 and in Frankfurt the DAX index decreased 60 or 0.5% to 12,376.71.
In Paris, CAC 40 index slid 5.16 to 5,304.06.
Adecco Group AG
slid 0.2% to 66.98 Swiss francs after Switzerland-based staffing services provider agreed to acquire the U.S.-based technology education provider General Assembly for $412.5 million or £289 million, including debt.
The transaction is expected to close during the second-quarter of this year.
Rocket Internet SE
advanced 1.1% to 25.16 after Germany-based incubator and internet provider said total revenues in the year ending in December surged 28% from a year ago 2.64 billion.
Net loss in the year narrowed to 6 million from 741.5 million in a year ago period and diluted loss per share decreased to 0.1 from 4.22.
Rocket Internet plans to terminate early its share buyback program for up to 5.5 million.
dropped 3.4% to 41.29 after Germany-based enterprise software provider reported revenues in the year ending in December increased 1% from a year ago to 878.9 million.
Net profit in the year rose 0.3% to 140.6 million from 140.2 million in a year ago period and diluted earnings per share increased to 2.38 from 2.37.
Revenues license business declined 2% to 256.7 million but maintenance revenues increased 2% to 421.6 million and revenues in the digital business platform (licenses and maintenance) declined 13.1%.
The enterprise software provider lifted fiscal 2018 revenues in IoT and cloud forecast to grow between 100% and 135% from earlier estimate of 70% to 100% and earnings per share of about 2.38.
increased 0.8% to 3,638.50 pence after the Ireland-based specialty drug maker agreed to sell its oncology unit to France-based privately held rival Servier S.A.S. for $2.4 billion in cash.
In fiscal 2017, Shires Oncology business generated revenues jumped 9.2% to $262 million.
The transaction is expected to close in the second or third-quarter of 2018.